RET Gene Fusions in Malignancies of the Thyroid and Other Tissues
Open Access
- 15 April 2020
- Vol. 11 (4), 424
- https://doi.org/10.3390/genes11040424
Abstract
Following the identification of the BCR-ABL1 (Breakpoint Cluster Region-ABelson murine Leukemia) fusion in chronic myelogenous leukemia, gene fusions generating chimeric oncoproteins have been recognized as common genomic structural variations in human malignancies. This is, in particular, a frequent mechanism in the oncogenic conversion of protein kinases. Gene fusion was the first mechanism identified for the oncogenic activation of the receptor tyrosine kinase RET (REarranged during Transfection), initially discovered in papillary thyroid carcinoma (PTC). More recently, the advent of highly sensitive massive parallel (next generation sequencing, NGS) sequencing of tumor DNA or cell-free (cfDNA) circulating tumor DNA, allowed for the detection of RET fusions in many other solid and hematopoietic malignancies. This review summarizes the role of RET fusions in the pathogenesis of human cancer.Funding Information
- National Institutes of Health (1R01CA197178-01A1R)
This publication has 126 references indexed in Scilit:
- Identification of kinase fusion oncogenes in post-Chernobyl radiation-induced thyroid cancersJCI Insight, 2013
- The Cancer Genome Atlas Pan-Cancer analysis projectNature Genetics, 2013
- DNA Topoisomerases Participate in Fragility of the Oncogene RETPLOS ONE, 2013
- DNA breaks at fragile sites generate oncogenic RET/PTC rearrangements in human thyroid cellsOncogene, 2010
- HOOK3-RET: a novel type of RET/PTC rearrangement in papillary thyroid carcinomaEndocrine-Related Cancer, 2007
- Structure and Chemical Inhibition of the RET Tyrosine Kinase DomainJournal of Biological Chemistry, 2006
- Low Prevalence of RET Rearrangements (RET/PTC1, RET/PTC2, RET/PTC3, and ELKS-RET) in Sporadic Papillary Thyroid Carcinomas in Taiwan ChineseThyroid®, 2005
- RET Rearrangements in Radiation-Induced Papillary Thyroid Carcinomas: High Prevalence of Topoisomerase I Sites at Breakpoints and Microhomology-Mediated End Joining in ELE1 and RET Chimeric GenesGenomics, 2001
- The RFG oligomerization domain mediates kinase activation and re-localization of the RET/PTC3 oncoprotein to the plasma membraneOncogene, 2001
- The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomasOncogene, 1999